nach oben

Graefe's Archive for Clinical and Experimental Ophthalmology

Erschienen in:

24.01.2018 | Letter to the Editor (by invitation)

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment — reply to the letter to the editor

verfasst von: Sonja Karst, Christoph Mitsch, Christoph Scholda, Ursula Schmidt-Erfurth

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Excerpt

We thank Dan and Mihai Călugăru for their letter and interest in our article [1]. In the study we presented, we included patients with visual impairment secondary to center involving diabetic macula edema (DME) (in our paper, we used this term to define central retinal subfield-thickness of more than 300 μm measured with spectral-domain OCT (see Methods section) . We used well-established inclusion criteria that are commonly used in DME trials: central retinal thickness (CRT) > 300 μm in spectral-domain optical coherence tomography (SD-OCT) and best-corrected visual acuity (BCVA) 20/25–20/400 Snellen equivalent. …

Karst SG, Lammer J, Mitsch C et al (2018) Detailed analysis of retinal morphology in patients with diabetic macular edema ( DME ) randomized to ranibizumab or triamcinolone treatment. Graefes Arch Clin Exp Ophthalmol 256(1):49–58CrossRefPubMed

Elman M, Aiello L, Beck R, Bressler N (2010) Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 117(6):1064–1077. https://doi.org/10.1016/j.ophtha.2010.02.031.Randomized CrossRefPubMedPubMedCentral

Mitchell P, Bandello F, Schmidt-Erfurth U et al (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615–625. https://doi.org/10.1016/j.ophtha.2011.01.031 CrossRefPubMed

Bressler SB, Glassman AR, Almukhtar T et al (2016) Five-year outcomes of ranibizumab with prompt or deferred laser versus laser or triamcinolone plus deferred ranibizumab for diabetic macular edema. Am J Ophthalmol 164:57–68. https://doi.org/10.1016/j.ajo.2015.12.025 CrossRefPubMedPubMedCentral

Schmidt-Erfurth U, Lang GE, Holz FG et al (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 121(5):1045–1053. https://doi.org/10.1016/j.ophtha.2013.11.041 CrossRefPubMed

Titel: Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment — reply to the letter to the editor
verfasst von: Sonja Karst
Christoph Mitsch
Christoph Scholda
Ursula Schmidt-Erfurth
Publikationsdatum: 24.01.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 5/2018
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-018-3902-3

Neu im Fachgebiet Augenheilkunde

08.04.2024 | Therapieverfahren in der Augenheilkunde | CME

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment — reply to the letter to the editor

Excerpt

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

Bestmögliche Wundheilung der Kornea dank optimaler pharmakologischer Therapie

Update Augenheilkunde

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2018

Individual benefits of enoxaparin treatment in branch vein occlusion

Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema

Preexisting epiretinal membrane is associated with pseudophakic cystoid macular edema

MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial

An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study

Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Bakterielle endogene Endophthalmitis

Bestmögliche Wundheilung der Kornea dank optimaler pharmakologischer Therapie

Update Augenheilkunde